iatroX logo
brainstormaskiatroX
knowledge centreblog
Knowledge Centre / Carcinoid Syndrome and Neuroendocrine Tumours (NETs)

Carcinoid Syndrome and Neuroendocrine Tumours (NETs)

Overview and management of neuroendocrine tumours.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 30 August 2025
GastroenterologyEndocrinologyOncology

Clinical Guidelines

ENETS 2017 Consensus Guidelines for the Diagnosis and Treatment of Neuroendocrine Tumors
National
UKINETS bitesize guidance - Peri-operative management of NETs
National

Recent iatroX Q&As

  • What are the key clinical features of carcinoid syndrome that I should look for in patients with suspected neuroendocrine tumours?Updated: 8/22/2025
  • Which biochemical markers are most useful for diagnosing neuroendocrine tumours in primary care?Updated: 8/22/2025
  • How should I approach the management of a patient with carcinoid syndrome, particularly regarding symptom control?Updated: 8/22/2025
  • When should I consider referring a patient with suspected neuroendocrine tumours to a specialist?Updated: 8/22/2025
  • What follow-up strategies should I implement for patients diagnosed with neuroendocrine tumours after initial treatment?Updated: 8/22/2025
askiatroX
privacytermshow it workscpdinsights
Download on the App StoreGet it on Google Play